SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0000950123-11-009245
Filing Date
2011-02-04
Accepted
2011-02-04 16:16:49
Documents
2
Period of Report
2011-02-03
Filing Date Changed
2011-02-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f58195e8vk.htm 8-K 14316
2 EX-10.19 f58195exv10w19.htm EX-10.19 13192
  Complete submission text file 0000950123-11-009245.txt   29128
Mailing Address 2100 POWELL STREET EMERYVILLE CA 94608
Business Address 2100 POWELL STREET EMERYVILLE CA 94608 5105976500
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28298 | Film No.: 11574981
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1